Cytoskeletal agents inhibit motility and adherence of human tumor cells

Kidney Int. 1993 Jan;43(1):151-7. doi: 10.1038/ki.1993.25.

Abstract

Cytoskeletal agents have been demonstrated to inhibit stimulated motility and substrate adherence by the human tumor cell line, A2058. cis-tubulozole, taxol, and cytochalasin D were tested for their effects on chemotaxis in response to a tumor cytokine, autocrine motility factor, and on adherence to several substrata: laminin- and gelatin-coated dishes as well as tissue culture plastic. Cytochalasin D, which inhibits microfilament polymerization, abolished stimulated motility. Taxol, which stabilizes microtubules, decreased stimulated motility to a greater degree than cis-tubulozole, which inhibits microtubular polymerization. In contrast, cis-tubulozole had the greatest inhibitory effect on adherence with a gelatin substratum more affected (100% inhibition) than tissue culture plastic (90%) or laminin substratum (52%). Taxol affected adherence in the same order but less than cis-tubulozole. Cytochalasin D had no significant effect on adherence to laminin with moderate inhibition of adherence to tissue culture plastic or gelatin. These data suggest that, in these tumor cells, microfilaments are more crucial for motility than adherence, but the dynamic polymerization and depolymerization of microtubules are required for both types of cellular activities.

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Cell Adhesion / drug effects
  • Cell Movement / drug effects
  • Chemotaxis / drug effects
  • Cytochalasin B / pharmacology
  • Cytochalasin D / pharmacology
  • Cytoskeleton / drug effects*
  • Dioxolanes / pharmacology
  • Humans
  • Paclitaxel / pharmacology
  • Tumor Cells, Cultured / drug effects*
  • Tumor Cells, Cultured / pathology
  • Tumor Cells, Cultured / physiology

Substances

  • Antineoplastic Agents
  • Dioxolanes
  • Cytochalasin D
  • Cytochalasin B
  • tubulazole
  • Paclitaxel